Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...
Novavax Inc (NVAX) reports increased product sales and a strong cash position, while revising revenue guidance and navigating market dynamics.
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript
Good morning and welcome to Novavax' Third Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation,
Novavax Q3 Earnings A Week Away - Time To Accept A New Reality
Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock valuation will fall over time. Learn more on NVAX stock here.
StoneCo (STNE) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Nov 12, 2024, 5:00 p.m. ET Good evening, everyone. Thank you for standing by. Welcome to StoneCo's third quarter 2024 earnings conference call. By now, everyone should have access to our earnings release.
Cava Group (CAVA) Q3 2024 Earnings Call Transcript
Operator Good afternoon, ladies and gentlemen, and welcome to the CAVA third quarter 2024 earnings conference call. [Operator instructions] This call is being recorded on Tuesday, November 12th, 2024.
Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript
Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET
Mosaic (MOS) Q3 2024 Earnings Call Transcript
Good morning, everyone, and welcome to The Mosaic Company's third-quarter 2024 earnings conference call. At this time, all participants have been placed in a listen-only mode. After the company completes their prepared remarks,
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
Welcome ladies and gentlemen to AstraZeneca's nine months and Q3 results 2024 webinar for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the Safe Harbor statement. The company intends to utilize the Safe Harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
Camtek (CAMT) Q3 2024 Earnings Call Transcript
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Camtek wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Hosted on MSN
2d
Novavax falls after guidance cut on lower vaccine sales
Novavax (NASDAQ:
NVAX
) shares lost ~12% in the premarket on Tuesday after the Gaithersburg, MD-based biotech, with its Q3 ...
1d
Novavax price target lowered to $12 from $14 at BofA
BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...
1d
Novavax to Participate in Jefferies London Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
Business Wire
25d
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
1d
Novavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market Outlook
Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Novavax (NVAX – Research Report), reducing the price ...
2d
Earnings Outlook For Novavax
Analysts are estimating that Novavax will report an earnings per share (EPS) of $-0.87. Anticipation surrounds Novavax's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Novavax
COVID
Food and Drug Administration
Nuvaxovid
Feedback